November 27, 2007 - Gamma Medica-Ideas Inc. has announced its collaboration with Mayo Clinic on a new breast cancer research project, the primary goal of which is to document the advantages of using GM-I’s LumaGEM dual-headed Molecular Breast Imaging (MBI) technology for the early detection, diagnosis and treatment of breast cancer. The project is funded by a grant from the National Cancer Institute.

Researchers also hope to prove LumaGEM’s capabilities in breast cancer staging, therapy planning, monitoring and follow-up. The two-phase collaborative project will enroll approximately 500 patients. Project researchers will use the LumaGEM MBI imager to noninvasively define the characteristics of a patient’s breast cancer cells at a molecular level by using established and novel radioactive markers. During Phase I, a dual-headed CZT LumaGEM will be installed at Mayo Clinic. In phase II, an additional LumaGEM system will be installed at Cedars-Sinai (Los Angeles, CA). Dr. Iraj Khalkhali (Los Angeles, CA) will take delivery of yet another LumaGEM. The patient studies will be conducted with all three systems to compare the diagnostic capabilities of this device to Magnetic Resonance Imaging (MRI). Mayo Clinic will subsequently evaluate promising new radiopharmaceuticals for the detection of breast cancer. Finally, Cedars-Sinai will conduct a study demonstrating the dual-isotope capability of this system and compare the diagnostic potential of both isotopes.

Gamma Medica-Ideas’ LumaGEM is a dedicated gamma camera used for diagnostic imaging, including MBI. The LumaGEM system features fully solid state digital detection utilizing eV Products Cadmium Zinc Telluride (CZT) to provide superior resolution compared with the conventional scintillation camera technology traditionally used in gamma cameras, the company says. It also reportedly allows minimal dead space at the edges of the image, permitting the closest access to the chest wall.

For more information: www.gm-ideas.com


Related Content

News | Radiation Therapy

January 19, 2024 — Treating tumors is a global health issue. In radiotherapy, radiation is used to destroy tumor cells ...

Time January 19, 2024
arrow
Feature | PET Imaging

According to a new report from Transparency Market Research (TMR), PET radiotracers are expected to rise at a CAGR of 8 ...

Time September 05, 2023
arrow
News | Radiology Imaging

August 24, 2023 — Medical imaging via X-rays, CT scans, MRIs and ultrasounds provide health-care professionals with ...

Time August 24, 2023
arrow
News | SNMMI

June 28, 2023 — A novel PET perfusion radiotracer, 18F-flurpiridaz, can diagnose coronary artery disease (CAD) in obese ...

Time June 28, 2023
arrow
News | Radiopharmaceuticals and Tracers

April 3, 2023 — NorthStar Medical Radioisotopes, LLC, a global innovator in the development, production and ...

Time April 03, 2023
arrow
News | Molecular Imaging

March 29, 2023 — A newly published literature review sheds light on how nuclear medicine brain imaging can help evaluate ...

Time March 29, 2023
arrow
News | SPECT-CT

March 2, 2023 —Royal Philips announced new milestones in the development of the world’s first spectral detector angio CT ...

Time March 02, 2023
arrow
News | Nuclear Imaging

February 23, 2023 — Editor's note: This news item has been updated to reflect that the FDA has since updated its alert ...

Time February 15, 2023
arrow
News | Cardiac Imaging

January 13, 2023 — Nuclear stress testing performed with single-photon emission computed tomography (SPECT) is the most ...

Time January 13, 2023
arrow
News | Radiology Business

January 5, 2023 — StreamlineMD has provided updates for 2023 Radiology and IR CPT coding, which may impact your practice ...

Time January 05, 2023
arrow
Subscribe Now